Search

Displaying all 3 results
DrugBest match

Suvorexant

go.drugbank.com/drugs/DB09034
ApprovedInvestigational

Suvorexant is a selective dual antagonist of orexin receptors OX1R and OX2R that promotes sleep by reducing wakefulness and arousal. It has been approved for the treatment of insomnia.

  1. Drug

    Lemborexant

    go.drugbank.com/drugs/DB11951
    ApprovedInvestigational

    [suvorexant]) act to counteract inappropriate wakefulness.

  2. Drug

    Daridorexant

    go.drugbank.com/drugs/DB15031
    ApprovedInvestigational

    [L39660] as the second orexin receptor antagonist approved to treat insomnia following [suvorexant].